Search results for " patients" in Articles / App Notes
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
…o you usually have when you interact with Asian biopharmaceutical producers?
The sheer number of patients to be supplied with therapeutics and vaccines, often with insufficient support from healt…
Article
Impurity Testing of Biologic Drug Products
Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
By Adeline Siew, PhD
CA-SSIS/shutterstock.comIm…
Article
Exotoxin Clearance from mAb Samples in a Two-Step Chromatography Process
A heat-stable exotoxin can remain as a contaminant of a drug substance throughout the whole manufacturing process, with the risk of adversely affecting patients’ health. One such toxin is cereulide …
Article
Techniques for Improving Process Development for Exosome-Derived Therapeutics
An interview with Aaron Noyes, Head of Downstream Processing at Codiak BioSciences
Some therapeutic targets have long frustrated drug developers hoping to crack the code of mitigating un…
Article
What's in Your SOP?
…ns, and best practices for ensuring consistent, reliable, and safe medications or medical devices to patients.
SOPs should be written to allow your personnel to conduct operations in …
Article
Reliability Rooms and the Move to Proactive Supply Chain Management
…throughout the company to measure performance against internal benchmarks, but with a clear focus on patients and healthcare providers.
Inspiration for this program came from the Toyota Product…
Article
ADC Development Robust Despite Lackluster Performance
ADC Development Robust Despite Lackluster Performance
Despite the disappointing therapeutic performance of ADCs thus far, the pipeline still boasts promising prospects.
By Feliza…
Article
Platform Technologies Improve Protein Expression
…ational modifications that meet the needs of the pharmaceutical industry, physicians, and ultimately patients in need of novel medications,” notes Bjørn Voldborg, director of CHO cell-line developmen…
Article
Bioburden Control in the Biopharmaceutical Industry
Microbial contamination and spoilage are among the most challenging problems that affect biologics manufacturers and patients. Thus, a continuous microbiological monitoring plan, coupled with SPC, sho…
Article
Process Chromatography: Continuous Optimization
There is a need for more economic downstream processes to ensure that modern therapeutic regimes can be offered to more patients worldwide,” observes Bulpin.
Adds Terova: “The landscape in molecul…